| SC 13G/A | 2024-04-05 | WELLINGTON MANAGEMENT GROUP LLP | ROCKET PHARMACEUTICALS, INC. | 9,156,099 | 10.1% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | ROCKET PHARMACEUTICALS, INC. | 5,447,565 | 6.0% | EDGAR |
| SC 13G | 2024-02-08 | WELLINGTON MANAGEMENT GROUP LLP | ROCKET PHARMACEUTICALS, INC. | 8,197,546 | 9.1% | EDGAR |
| SC 13G/A | 2024-01-29 | BlackRock Inc. | ROCKET PHARMACEUTICALS, INC. | 5,930,178 | 6.6% | EDGAR |
| SC 13G/A | 2024-01-22 | STATE STREET CORP | ROCKET PHARMACEUTICALS, INC. | - | 3.6% | EDGAR |
| SC 13D/A | 2023-09-19 | RTW INVESTMENTS, LP | ROCKET PHARMACEUTICALS, INC. | 18,188,457 | - | EDGAR |
| SC 13D/A | 2023-04-05 | RTW INVESTMENTS, LP | ROCKET PHARMACEUTICALS, INC. | 18,188,457 | - | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | ROCKET PHARMACEUTICALS, INC. | 4,186,542 | 5.3% | EDGAR |
| SC 13G/A | 2023-02-06 | WELLINGTON MANAGEMENT GROUP LLP | ROCKET PHARMACEUTICALS, INC. | 3,507,017 | 4.4% | EDGAR |
| SC 13G/A | 2023-01-31 | BlackRock Inc. | ROCKET PHARMACEUTICALS, INC. | 5,587,535 | 7.1% | EDGAR |
| SC 13G | 2023-01-31 | STATE STREET CORP | ROCKET PHARMACEUTICALS, INC. | - | 5.0% | EDGAR |
| SC 13D/A | 2022-10-11 | RTW INVESTMENTS, LP | ROCKET PHARMACEUTICALS, INC. | 17,628,567 | - | EDGAR |
| SC 13D/A | 2022-09-21 | RTW INVESTMENTS, LP | ROCKET PHARMACEUTICALS, INC. | 16,272,635 | - | EDGAR |
| SC 13G/A | 2022-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | ROCKET PHARMACEUTICALS, INC. | 2,192,894 | 3.4% | EDGAR |
| SC 13G/A | 2022-02-14 | PERCEPTIVE ADVISORS LLC | ROCKET PHARMACEUTICALS, INC. | 1,959,125 | 3.0% | EDGAR |
| SC 13G/A | 2022-02-14 | TANG CAPITAL PARTNERS LP | ROCKET PHARMACEUTICALS, INC. | 2,531,800 | 3.9% | EDGAR |
| SC 13G | 2022-02-10 | VANGUARD GROUP INC | ROCKET PHARMACEUTICALS, INC. | 3,301,138 | 5.1% | EDGAR |
| SC 13G | 2022-02-04 | BlackRock Inc. | ROCKET PHARMACEUTICALS, INC. | 3,339,469 | 5.2% | EDGAR |
| SC 13G | 2022-02-04 | WELLINGTON MANAGEMENT GROUP LLP | ROCKET PHARMACEUTICALS, INC. | 3,490,879 | 5.4% | EDGAR |
| SC 13D/A | 2021-08-31 | RTW INVESTMENTS, LP | ROCKET PHARMACEUTICALS, INC. | 16,272,635 | 25.3% | EDGAR |